Lamotrigine is the preferred antiepileptic in women of childbearing age partly due to lower teratogenicity than valproate. However, lamotrigine levels can drop significantly during pregnancy, requiring dose adjustment. The mechanism is:

• A Decreased GI absorption of lamotrigine due to pregnancy-related alkalosis
• B Increased renal excretion due to elevated GFR in pregnancy
• C Estrogen-mediated induction of UGT1A4, the glucuronidating enzyme for lamotrigine ✓
• D Progesterone competitive inhibition at the lamotrigine sodium channel binding site

Explanation

Lamotrigine is primarily metabolized by UGT1A4 (UDP-glucuronosyltransferase). Estrogen levels rise progressively during pregnancy and strongly induce UGT1A4, accelerating lamotrigine glucuronidation and clearance. Plasma lamotrigine levels can fall by 50-70% during pregnancy, risking breakthrough seizures. Doses often need escalation in the second and third trimesters, with dose reduction postpartum to avoid toxicity.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.